NEWS & UPDATES
Martin Shkreli, a then CEO of Turo Pharmaceuticals became infamous when he increased the price of Daraprim, a medication used to treat toxoplasmosis that immunosuppressive patients are most susceptible to. This has led to concerns about the ever growing problem of increased drug costs.
Mylan has recently launched the generic version of Crestor, (known as rosuvastatin) in strengths of 5, 10, 20 and 40 mg. Rosuvastatin is used to treat patients with hypertriglyceridemia and hypercholesteremia.
Atovaquone, an anti-malarial drug, has been used to promote the cancer-killing abilities of radiation. It has been recently discovered that it can also be used as a radiotherapy adjunct after it was identified in a screen of drugs capable of reducing tumors.
Researchers at the University of Chicago have discovered long term treatment with broad spectrum antibiotics decreased levels of amyloid plaques, a charateristic of Alzheimer's Disease in the brains of mice.
An ER in New Jersey has replaced using opiods to treat patients with pain with other alternatives such as laughing gas, trigger point injections and a therapeutic harp.
The United States is seeing another drug resistant 'superbug' that is threatening the efficacy of antibiotics that modern medicine relies on.
Marialice S. Bennett, RPh, FAPhA, shares her ideas about the traits shared by leaders tasked with motivating managers and how to drive an idea forward into action.
The Senate approved a bill to combat opiod addiction crisis by giving medical professionals and law enforcement more tools to help drug addicts and expand access to a drug that emergency medical workers can use if they encoutner a patient who has overdosed on opiods.
The competing companies that make Humira and Enbrel are creating new patents to prevent patients and insurance companies from obtaining the generic versions of these medications for a cheaper cost.
A reader asks if prolonged use of statin drugs, such as Lipitor can cause diabetes.
This demonstrates why being apart of a dedicated and motivated association of innovators is so important. "As innovators work with understandably reluctant executives and boards, it's wise to not only describe a compelling business and clinical case, but to be prepared to address the mental errors that can otherwise undermine a good idea. It's not about manipulating the audience with spin, but consciously elevating unspoken concerns and explicitly and honestly addressing them."